Investor Stock List
Ranked #7,118 of 8,699 institutional investors

Propel Bio Management, LLC

Los Angeles, CA

$149M
US stock portfolio at live prices · today −$2.6M (−1.71%)
Market closed. Prices as of Nov 20, 8:11 AM ET
Value at quarter end (Q3 2026)
$181M
Change from Q2 2026
−$9.8M (−5.12%)
Positions
30 · 5 new, 4 sold out
Filed
Nov 13, 2026

Holdings

Q3 2026 13F, live prices
PAGP 22.2%QUIT 15.3%DCTH 7.83%COLL 6.96%OBIO 4.23%
StockSharesValue, live% of portfoliovs Q2 2026
PAGP Plains GP Holdings, L.P.1,272,360$32.9M22.2%Unchanged
QUIT Achieve Life Sciences, Inc.3,864,148$22.7M15.3%Reduced −4%
DCTH Delcath Systems, Inc.604,664$11.6M7.83%Reduced −31%
COLL Collegium Pharmaceutical, Inc.410,175$10.3M6.96%New
OBIO Orchestra BioMed Holdings, Inc.896,701$6.3M4.23%Unchanged
MAZE Maze Therapeutics, Inc.191,998$6.2M4.19%Added +338%
PHAT Phathom Pharmaceuticals, Inc.1,105,913$5.6M3.78%Added +5%
CORT Corcept Therapeutics Incorporated75,274$4.9M3.29%Reduced −45%
CMPS COMPASS Pathways plc549,186$4.8M3.20%Reduced −4%
IVA Inventiva S.A.1,133,954$3.9M2.63%Reduced −11%
MIST Milestone Pharmaceuticals Inc.9,449,727$3.8M2.54%Added +27%
SABS SAB Biotherapeutics, Inc.1,187,422$3.5M2.33%Added +10%
KYTX Kyverna Therapeutics, Inc.700,595$3.1M2.06%Reduced −21%
ARTV Artiva Biotherapeutics, Inc.696,436$2.7M1.80%Unchanged
CRVS Corvus Pharmaceuticals, Inc.264,310$2.6M1.78%Added +276%
OVID Ovid Therapeutics Inc.1,018,721$2.4M1.61%Reduced −9%
ABEO Abeona Therapeutics Inc.956,007$2.3M1.58%Reduced −3%
PROK ProKidney Corp.2,009,733$2.1M1.43%New
OCUL Ocular Therapeutix, Inc.357,966$2.1M1.41%Unchanged
CABA Cabaletta Bio, Inc.2,049,471$2.1M1.39%New
PALI Palisade Bio, Inc.2,224,189$2.1M1.39%Reduced −14%
FDMT 4D Molecular Therapeutics, Inc.179,154$1.9M1.29%Reduced −29%
IMUX Immunic, Inc.236,734$1.7M1.18%Reduced −27%
SCYX SCYNEXIS, Inc.541,474$1.4M0.95%Reduced −0%
SGP SpyGlass Pharma, Inc.41,418$1.3M0.86%New
IRD Opus Genetics, Inc.270,036$1.1M0.74%New
CLDX Celldex Therapeutics, Inc.37,539$1.0M0.71%Reduced −64%
AQST Aquestive Therapeutics, Inc.278,723$1.0M0.70%Reduced −81%
UPB Upstream Bio, Inc.335,389$671K0.45%Reduced −4%
LONA LeonaBio, Inc.149,279$367K0.25%Unchanged

Sold out in Q3 2026

StockShares held at Q2 2026Worth today
SLN Silence Therapeutics plc191,733$3.8M
ZVRA Zevra Therapeutics, Inc.253,544$2.3M
SGMT Sagimet Biosciences Inc.125,878$1.2M
EYPT EyePoint, Inc.191,745$51K